07:50 EDT Jade Biosciences (JBIO) up 16.5% at $10.65 after JADE201 announcement
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JBIO:
- Jade Biosciences Secures $135 Million in Private Placement
- Jade Biosciences prices 13.4M shares at $9.14 in private placement
- Jade Biosciences announces JADE201 afucosylated monoclonal antibody
- Jade Biosciences’ Chief Medical Officer Departs
- Jade Biosciences announces first cohort dosed in Phase 1 trial of JADE101